(3S)-1-(Pyrimidin-2-yl)pyrrolidin-3-amine hydrochloride, 1g

Tert-butyl (3S,4S)-3-(hydroxymethyl)-4-methylpyrrolidine-1-carboxylate, 98+%, 100mg

3-Amino- 2-methoxy-6-picoline, 97.0%, 10g

8-Bromo-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 95%, 250mg

tert-Butyl 2,6-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 1g

trans-3,4-Difluorocinnamic acid, 97.0%, 100g

2,2-Dimethylpyrrolidin-3-ol, 98%, 500mg

2-(2-Chlorophenoxy)acetamide, 98%, 5g

Recipiente de cristalización ROTILABO® con pico, 40 ml, 50 mm, 10 Unidad(es)

4-(3-Bromo-4-fluorobenzyl)morpholine, 95+%, 1g

Guanabenz Acetate>98.0%(HPLC)(T)200mg

6-HYDROXYIMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID, 95.0%, 100mg

3-Phenylcinnoline-4-carboxylic acid, 1g